Stay updated on Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice stating no participants are being sought. It also standardizes the Intervention/Treatment label and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check14 days agoChange DetectedA new revision entry 'Revision: v3.5.5' has been added to the revision history, replacing the previous 'Revision: v3.5.4', indicating a recent update to the page's content or metadata.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page now displays a newer revision label (v3.5.4) replacing the previous (v3.5.3), indicating an updated page revision.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page’s displayed system revision/version number was updated from v3.5.2 to v3.5.3, reflecting a change to the website release/renderer rather than study details.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision tag on the page updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page. This appears to be a metadata/version update and does not change study content or eligibility information.SummaryDifference0.1%

Stay in the know with updates to Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Dupilumab in Atopic Dermatitis Clinical Trial page.